Neutralizing Monoclonal Antibody Combo Treats Mild, Moderate COVID-19
For those at high risk, COVID-19-related hospitalization or death from any cause reduced with bamlanivimab/etesevimab versus placebo
Staff Size, COVID-19 Outcomes Linked at Skilled Nursing Facilities
Conventional measures of staff quality, including direct care staff-to-resident ratio did not predict COVID-19 cases, deaths
Outpatient Antibiotic Prescribing Down in VA System
Annual percent decrease for all outpatient antibiotic use averaged 3.9 percent; largest decrease seen in ciprofloxacin use at 12.6 percent
Restrictive Eating Disorders Up Among Teens During Pandemic
For first 12 months of pandemic, number of admissions at children's hospital more than double for same period in previous three years
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
Disease-free survival did not improve with two years of celecoxib versus placebo in ERBB2-negative breast cancer
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
No difference in overall survival seen with nivolumab plus ipilimumab, nivolumab alone for advanced, chemotherapy-pretreated disease
High-Dose Buprenorphine Induction in ED Seems Safe for Treating OUD
High-dose buprenorphine protocol well tolerated in patients with untreated opioid use disorder; no reports of respiratory depression or sedation
Globally, 8 Percent of Men Who Have Sex With Men Have Syphilis
Researchers say this is 15 times higher than estimates for men in the general population
Chinese Man Hospitalized With H5N6 Bird Flu
55-year-old, hospitalized in Bazhong, came down with a fever and tested positive for the virus on July 6
Two Major Health Systems Will Not Administer Controversial Aduhelm
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
